Summit Therapeutics (SMMT) EPS (Basic) (2019 - 2024)
Summit Therapeutics (SMMT) posted EPS (Basic) of -$0.1 for Q4 2024, down 21.22% on a QoQ basis from -$0.08 in Q3 2024, and down 60.62% year-over-year from -$0.26 in Q1 2024.
Summit Therapeutics (SMMT) EPS (Basic) (2019 - 2024) Analysis & Trends
Summit Therapeutics' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.1 for Q4 2024.
- Quarterly EPS (Basic) fell 60.62% year-over-year to -$0.1 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$0.1 (up 65.77% YoY) and the FY2024 annual result came in at -$2.65, down 166.98% from the prior year.
- EPS (Basic) was -$0.1 for Q4 2024 at Summit Therapeutics, down from -$0.08 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.03 in Q2 2023 and bottomed at -$1.44 in Q1 2023.
- A 5-year average of -$0.21 and a median of -$0.13 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 528.86% — and 2024, when it soared 95.5%.
- Summit Therapeutics' EPS (Basic) stood at -$0.19 in 2020, then slumped by 50.84% to -$0.29 in 2021, then soared by 64.26% to -$0.1 in 2022, then surged by 39.83% to -$0.06 in 2023, then slumped by 60.62% to -$0.1 in 2024.
- Business Quant data shows SMMT's EPS (Basic) at -$0.1 in Q4 2024, -$0.08 in Q3 2024, and -$0.09 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -1.44 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.13 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.29 |
| Sep 30, 2021 | -0.20 |
| Jun 30, 2021 | -0.27 |
| Mar 31, 2021 | -0.21 |
| Dec 31, 2020 | -0.19 |
| Sep 30, 2020 | -0.26 |
| Jun 30, 2020 | -0.23 |
| Mar 31, 2020 | -0.09 |